Chronic disease long‐term drug prevention trials: Lessons from the Alzheimer's Disease Anti‐inflammatory Prevention Trial (ADAPT)-Reference-Cited by-同舟云学术

Chronic disease long‐term drug prevention trials: Lessons from the Alzheimer's Disease Anti‐inflammatory Prevention Trial (ADAPT)

Published:2007-12-21 Issue:1S1 Volume:4 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Meinert Curtis L.¹,Breitner John C.S.²

Affiliation:

1. Department of EpidemiologyBloomberg School of Public HealthThe Johns Hopkins UniversityBaltimoreMDUSA

2. Division of Geriatric PsychiatryDepartment of Psychiatry and Behavioral SciencesUniversity of Washington School of Medicine, and VA Puget Sound Health Care SystemSeattleWAUSA

Funder

NIH National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2007.10.007

Reference40 articles.

1. Dementia: The leading predictor of death in a defined elderly population

2. Seven-Year Survival Rate After Age 85 Years: Relation to Alzheimer Disease and Vascular Dementia

3. The field trial: some thoughts on the indispensable ordeal;Fredrickson D.S.;Bull NY Acad Med,1968

4. Gender Representation in Trials

5. Estimation of gender bias in clinical trials;Meinert C.L.;Stat Med,2000

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mail and Telephone Outreach from Electronic Health Records for Research Participation on Cognitive Health and Aging;The Journal of Prevention of Alzheimer's Disease;2021

2. Evaluating the social value of online health information for third-party patients: Is uncertainty always bad?;Information Processing & Management;2020-09

3. Defining Microglial Phenotypes in Alzheimer’s Disease;Alzheimer's Disease - The 21st Century Challenge;2018-07-18

4. Targeting Neuroinflammation to Treat Alzheimer’s Disease;CNS Drugs;2017-12

5. Study partners should be required in preclinical Alzheimer’s disease trials;Alzheimer's Research & Therapy;2017-12